Biofilm-Forming Ability and Clonality in Acinetobacter baumannii Strains Isolated from Urine Samples and Urinary Catheters in Different European Hospitals.

Autor:	Vuotto C; Microbial Biofilm Laboratory, IRCCS Fondazione Santa Lucia, Rome, Italy. c.vuotto@hsantalucia.it., Grosso F; REQUIMTE. Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal., Longo F; Microbial Biofilm Laboratory, IRCCS Fondazione Santa Lucia, Rome, Italy., Balice MP; Clinical Microbiology Laboratory, IRCCS Fondazione Santa Lucia, Rome, Italy., de Barros MC; Microbial Biofilm Laboratory, IRCCS Fondazione Santa Lucia, Rome, Italy.; REQUIMTE. Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal., Peixe L; REQUIMTE. Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal., Donelli G; Microbial Biofilm Laboratory, IRCCS Fondazione Santa Lucia, Rome, Italy.
Jazyk:	angličtina
Zdroj:	Advances in experimental medicine and biology [Adv Exp Med Biol] 2018; Vol. 1057, pp. 73-83.
DOI:	10.1007/5584_2017_70
Abstrakt:	Objective: Biofilm formation has been associated with the persistence of Acinetobacter baumannii in hospital settings and its propensity to cause infection. We investigated the adhesion ability and clonality of 128 A. baumannii isolates recovered from urine and urinary catheters of patients admitted to 5 European hospitals during 1991-2013. Methods: Isolates identification was confirmed by rpoB sequencing and by the presence of blaOXA-51. The presence of carbapenemases was detected by PCR. Clonality was determined by Sequence Group (SG) identification, Pulsed field gel electrophoresis (PFGE) and Multilocus sequence typing. Adhesion ability was defined by quantitative biofilm production assay and biofilms were characterized by Confocal Laser Microscopy and Scanning Electron Microscopy. Results: The 128 isolates, either resistant (85.9%) or susceptible (14.1%) to carbapenems, and belonging to 50 different PFGE types and 24 different STs, were distributed among SG1 (67.2%), SG2 (10.2%) and other allelic profiles (22.7%). ST218 was the most frequent ST, corresponding to 54,5% of the isolates collected between 2011 and 2013. Among the 109 isolates showing resistance to at least 1 carbapenem, 55% revealed the presence of an acquired carbapenem-hydrolyzing class D - lactamases (CHDL): blaOXA-23 were the most frequent gene detected from 2008 onwards (75%). Among all the clinical isolates, 42.2% were strong biofilm producers, with the older isolates having the highest adhesion ability. Most isolates recovered later, belonging to ST218 and harbouring blaOXA-23, were homogeneously less adhesive. Conclusions: An evolution towards a decrease in adhesion ability and a CHDL content change was observed along the years in several European countries.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu